Literature DB >> 22700218

Mammalian Sulf1 RNA alternative splicing and its significance to tumour growth regulation.

Rai B S Gill1, Amy Day, Amy Barstow, Gul Zaman, Chantal Chenu, Gurtej K Dhoot.   

Abstract

SULF1/SULF2 enzymes regulate the activities of several growth factors by selective hydrolysis of 6-O-sulphates of heparan sulphate proteoglycan co-receptors, the sulfation of which is essential for signal transduction of some ligand/receptor interactions but not others. This study demonstrates the existence of SULF1 variants with a wide spectrum of splicing patterns in mammalian tumours. The levels and relative proportions of SULF1/SULF2 splice variants markedly vary in different tumours with a potential to regulate cell growth differentially. Although mammalian Sulf1 compared with Sulf2 gene generates a much larger number of splice variants, both enzymes follow generally similar distribution and signalling association trends in hepatocellular carcinomas.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22700218     DOI: 10.1007/s13277-012-0423-2

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  26 in total

Review 1.  Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate.

Authors:  Steven D Rosen; Hassan Lemjabbar-Alaoui
Journal:  Expert Opin Ther Targets       Date:  2010-09       Impact factor: 6.902

2.  Expression regulation and function of heparan sulfate 6-O-endosulfatases in the spermatogonial stem cell niche.

Authors:  Aliete Langsdorf; Valerie Schumacher; Xiaofeng Shi; Thanh Tran; Joseph Zaia; Sanjay Jain; Mary Taglienti; Jordan A Kreidberg; Alan Fine; Xingbin Ai
Journal:  Glycobiology       Date:  2010-09-20       Impact factor: 4.313

3.  Sulfatase 1 and sulfatase 2 in hepatocellular carcinoma: associated signaling pathways, tumor phenotypes, and survival.

Authors:  Ju Dong Yang; Zhifu Sun; Chunling Hu; Jinping Lai; Rebecca Dove; Ikuo Nakamura; Ju-Seog Lee; Snorri S Thorgeirsson; Koo Jeong Kang; In-Sun Chu; Lewis R Roberts
Journal:  Genes Chromosomes Cancer       Date:  2011-02       Impact factor: 5.006

4.  Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity.

Authors:  D A Pye; R R Vives; J E Turnbull; P Hyde; J T Gallagher
Journal:  J Biol Chem       Date:  1998-09-04       Impact factor: 5.157

5.  A novel SULF1 splice variant inhibits Wnt signalling but enhances angiogenesis by opposing SULF1 activity.

Authors:  Amrit Paul Sahota; Gurtej K Dhoot
Journal:  Exp Cell Res       Date:  2009-07-03       Impact factor: 3.905

Review 6.  Heparin-degrading sulfatases in hepatocellular carcinoma: roles in pathogenesis and therapy targets.

Authors:  Jin-Ping Lai; James R Thompson; Dalbir S Sandhu; Lewis R Roberts
Journal:  Future Oncol       Date:  2008-12       Impact factor: 3.404

7.  Domain-specific modification of heparan sulfate by Qsulf1 modulates the binding of the bone morphogenetic protein antagonist Noggin.

Authors:  Beth L Viviano; Stephenie Paine-Saunders; Nijole Gasiunas; John Gallagher; Scott Saunders
Journal:  J Biol Chem       Date:  2003-11-25       Impact factor: 5.157

8.  Sulf2 gene is alternatively spliced in mammalian developing and tumour tissues with functional implications.

Authors:  Rai B S Gill; Amy Day; Amy Barstow; Hongxiang Liu; Gul Zaman; Gurtej K Dhoot
Journal:  Biochem Biophys Res Commun       Date:  2011-09-24       Impact factor: 3.575

9.  QSulf1, a heparan sulfate 6-O-endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis.

Authors:  Shouwen Wang; Xingbin Ai; Stephen D Freeman; Mary E Pownall; Qun Lu; Daniel S Kessler; Charles P Emerson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-29       Impact factor: 11.205

10.  QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling.

Authors:  Xingbin Ai; Anh-Tri Do; Olga Lozynska; Marion Kusche-Gullberg; Ulf Lindahl; Charles P Emerson
Journal:  J Cell Biol       Date:  2003-07-14       Impact factor: 10.539

View more
  14 in total

1.  Expression of Sulf1 and Sulf2 in cartilage, bone and endochondral fracture healing.

Authors:  G Zaman; K A Staines; C Farquharson; P T Newton; J Dudhia; C Chenu; A A Pitsillides; G K Dhoot
Journal:  Histochem Cell Biol       Date:  2015-10-14       Impact factor: 4.304

2.  SULF1/SULF2 reactivation during liver damage and tumour growth.

Authors:  Kurtis Graham; Joshua I Murphy; Gurtej K Dhoot
Journal:  Histochem Cell Biol       Date:  2016-03-25       Impact factor: 4.304

3.  Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple RNA-Seq datasets.

Authors:  Lu Zhang; Xiaoqiao Liu; Xuegong Zhang; Ronghua Chen
Journal:  Mol Genet Genomics       Date:  2015-12-28       Impact factor: 3.291

Review 4.  Proteoglycans and their roles in brain cancer.

Authors:  Anna Wade; Aaron E Robinson; Jane R Engler; Claudia Petritsch; C David James; Joanna J Phillips
Journal:  FEBS J       Date:  2013-02-06       Impact factor: 5.542

5.  Short SULF1/SULF2 splice variants predominate in mammary tumours with a potential to facilitate receptor tyrosine kinase-mediated cell signalling.

Authors:  Roop Ms Gill; Vedika Mehra; Emma Milford; Gurtej K Dhoot
Journal:  Histochem Cell Biol       Date:  2016-06-13       Impact factor: 4.304

6.  SULF 1 gene polymorphism, rs6990375 is in significant association with fetus failure in IVF technique.

Authors:  Eskandar Taghizadeh; Seyed Mehdi Kalantar; Reza Mahdian; Mohammad Hasan Sheikhha; Ehsan Farashahi-Yazd; Saeed Ghasemi; Zahra Shahbazi
Journal:  Iran J Reprod Med       Date:  2015-04

7.  Splicing imbalances in basal-like breast cancer underpin perturbation of cell surface and oncogenic pathways and are associated with patients' survival.

Authors:  Filipe Gracio; Brian Burford; Patrycja Gazinska; Anca Mera; Aisyah Mohd Noor; Pierfrancesco Marra; Cheryl Gillett; Anita Grigoriadis; Sarah Pinder; Andrew Tutt; Emanuele de Rinaldis
Journal:  Sci Rep       Date:  2017-01-06       Impact factor: 4.379

8.  HS and Inflammation: A Potential Playground for the Sulfs?

Authors:  Rana El Masri; Yoann Crétinon; Evelyne Gout; Romain R Vivès
Journal:  Front Immunol       Date:  2020-04-03       Impact factor: 7.561

9.  Restoration of epigenetically silenced SULF1 expression by 5-aza-2-deoxycytidine sensitizes hepatocellular carcinoma cells to chemotherapy-induced apoptosis.

Authors:  Abdirashid Shire; Gwen Lomberk; Jin-Ping Lai; Hongzhi Zou; Norihiko Tsuchiya; Ileana Aderca; Catherine D Moser; Kadra H Gulaid; Abdul Oseini; Chunling Hu; Omar Warsame; Robert B Jenkins; Lewis R Roberts
Journal:  Med Epigenet       Date:  2015 Jan-Apr

10.  Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.

Authors:  Lin Li; Qingsong Lei; Shujun Zhang; Lingna Kong; Bo Qin
Journal:  Oncol Rep       Date:  2017-09-07       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.